Who owns PHAT?
Institutional ownership of Phathom Pharmaceuticals Inc. from Form 13F, Q2 2026
162 institutional managers reported holding Phathom Pharmaceuticals Inc. (PHAT) in Form 13F filings for Q2 2026, with 72,073,934 shares worth $782M. The largest reported holder was Frazier Life Sciences Management, L.P. Managers that filed both quarters added a net 2,937,842 shares (+4.3%). 21 opened new positions and 32 sold out.
- Funds holding
- 162
- Value held
- $782M
- New / sold out
- 21 / 32
- Net shares, same filers
- +4.3%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of PHAT
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $135M | 17.3% | 12,466,489 | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | $81.0M | 10.4% | 7,464,572 | Unchanged |
| BlackRock, Inc. | $49.1M | 6.3% | 4,525,129 | Added |
| Invesco Ltd. | $43.7M | 5.6% | 4,029,731 | Trimmed |
| Carlyle Group Inc. | $37.9M | 4.9% | 3,496,808 | Unchanged |
| Millennium Management LLC | $36.6M | 4.7% | 3,375,834 | Trimmed |
| Vanguard Capital Management LLC | $28.8M | 3.7% | 2,656,944 | Added |
| GW&K Investment Management, LLC | $23.5M | 3.0% | 2,166,838 | Added |
| Franklin Resources Inc | $21.4M | 2.7% | 1,970,828 | Added |
| NEA Management Company, LLC | $21.3M | 2.7% | 1,960,169 | Unchanged |
| 683 Capital Management, LLC | $20.1M | 2.6% | 1,850,000 | Unchanged |
| Goldman Sachs Group Inc | $19.3M | 2.5% | 1,778,032 | Added |
| State Street Corp | $17.2M | 2.2% | 1,586,323 | Added |
| Catalys Pacific, LLC | $16.2M | 2.1% | 1,493,854 | Unchanged |
| Nomura Asset Management International Inc. | $15.9M | 2.0% | 1,462,738 | Added |
| Geode Capital Management, LLC | $14.3M | 1.8% | 1,315,687 | Trimmed |
| Wasatch Advisors LP | $14.2M | 1.8% | 1,307,247 | Trimmed |
| Ensign Peak Advisors, Inc | $11.4M | 1.5% | 1,051,913 | Trimmed |
| Propel Bio Management, LLC | $11.4M | 1.5% | 1,050,358 | Added |
| Point72 Asset Management, L.P. | $11.1M | 1.4% | 1,022,193 | New |
| Vanguard Portfolio Management LLC | $8.6M | 1.1% | 796,631 | Added |
| SummitTX Capital, L.P. | $8.6M | 1.1% | 789,550 | Trimmed |
| HSBC Holdings PLC | $7.7M | 1.0% | 709,695 | New |
| Marshall Wace, LLP | $7.2M | 0.9% | 666,090 | Trimmed |
| EcoR1 Capital, LLC | $6.8M | 0.9% | 625,000 | Unchanged |
Share of 13F holdings is each fund's shares as a share of the 72,073,934 PHAT shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Goldman Sachs Group Inc Added+$12.5M
- Point72 Asset Management, L.P. New+$11.1M
- Franklin Resources Inc Added+$10.6M
- GW&K Investment Management, LLC Added+$8.1M
- HSBC Holdings PLC New+$7.7M
- BlackRock, Inc. Added+$5.0M
- Nomura Asset Management International Inc. Added+$2.8M
- Jane Street Group, LLC New+$2.3M
- Propel Bio Management, LLC Added+$2.3M
- State Street Corp Added+$2.2M
Biggest sellers in Q2 2026
- Millennium Management LLC Trimmed-$7.0M
- Ensign Peak Advisors, Inc Trimmed-$6.2M
- Perceptive Advisors LLC Trimmed-$4.3M
- Avidity Partners Management LP Trimmed-$3.2M
- Invesco Ltd. Trimmed-$3.2M
- Susquehanna Portfolio Strategies, LLC Sold out-$3.0M
- Catalio Capital Management, LP Sold out-$2.8M
- Squarepoint Ops LLC Trimmed-$2.6M
- SummitTX Capital, L.P. Trimmed-$2.2M
- Citadel Advisors LLC Trimmed-$2.2M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $89.2M and sold $57.6M; 59 added and 50 trimmed.
Schedule 13D and 13G filings on PHAT
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-07-29BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2026-03-12MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Phathom Pharmaceuticals Inc.Schedule 13G
- 2025-08-13MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Phathom Pharmaceuticals Inc.Schedule 13G
Questions about PHAT ownership
- Who owns PHAT stock?
- 162 institutional investment managers reported PHAT positions in their Form 13F filings for Q2 2026, holding 72,073,934 shares worth $782M in total. Frazier Life Sciences Management, L.P. reported the largest position.
- Are funds buying or selling PHAT?
- In Q2 2026, 21 managers opened new PHAT positions, 59 added, 50 trimmed and 32 sold out. Managers that filed in both quarters added a net 2,937,842 shares.
- How current is this PHAT institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to PHAT by CUSIP. Options are left out. PHAT news and filings · PHAT insider trades · Top funds